Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hubert Marotte

Showing results (51-60 of 145) with videos related to

Pageof 15
Sort By:
Joint Bone Spine|October 5, 2016
High prevalence of dementia in women with osteoporosisAdamah Amouzougan, Ludovic Lafaie, Hubert Marotte, et al.
Arthritis Research & Therapy|April 26, 2014
Blocking the janus-activated kinase pathway reduces tumor necrosis factor alpha-induced interleukin-18 bioactivity by caspase-1 inhibitionHubert Marotte, Pei-Suen Tsou, Tatiana Fedorova, et al.
Therapeutic Advances in Musculoskeletal Disease|July 22, 2021
Immunomodulation with IL-17 and TNF-α in spondyloarthritis: focus on the eye and the central nervous systemElsa How Shing Koy, Pierre Labauge, Athan Baillet, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 25, 2025
Combination Therapy Using Embolization, Gelified Alcohol Sclerotherapy, and Vertebroplasty to Treat Aggressive Vertebral Hemangioma: Technique and Initial ResultsSylvain Grange, Thierry Thomas, Lucile Grange, et al.
Joint Bone Spine|August 1, 2017
Retro-odontoid pseudo-tumor due to calcium pyrophosphate crystal deposits with spinal cord compression and histopathological confirmationLambert Mijola, Adamah Amouzougan, Fabrice-Guy Barral, et al.
Journal of Clinical Medicine|April 18, 2019
How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?-MTX in the Treat-to-Target StrategyPeter C Taylor, Alejandro Balsa Criado, Anne-Barbara Mongey, et al.
Mediators of Inflammation|September 6, 2019
Implication of IL-17 in Bone Loss and Structural Damage in Inflammatory Rheumatic DiseasesBenoit Le Goff, Béatrice Bouvard, Thierry Lequerre, et al.
Arthritis and Rheumatism|June 28, 2006
Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatmentMyew-Ling Toh, Hubert Marotte, Jean-Luc Blond, et al.
Joint Bone Spine|January 14, 2021
Factors associated with back complaints among French medical studentsCarole Pelissier, Joséphine Lemaitre, Hubert Marotte, et al.
Advances in Therapy|July 28, 2025
Real-World Effectiveness and Safety of Infliximab Biosimilar CT-P13 for Rheumatic Diseases: A National Observational Cohort Study (ReFLECT)Hubert Marotte, Alain Cantagrel, Fabienne Coury, et al.
Pageof 15

Showing results (51-60 of 145) with videos related to

Sort By:
Pageof 15
Joint Bone Spine|October 5, 2016
High prevalence of dementia in women with osteoporosisAdamah Amouzougan, Ludovic Lafaie, Hubert Marotte, et al.
Arthritis Research & Therapy|April 26, 2014
Blocking the janus-activated kinase pathway reduces tumor necrosis factor alpha-induced interleukin-18 bioactivity by caspase-1 inhibitionHubert Marotte, Pei-Suen Tsou, Tatiana Fedorova, et al.
Therapeutic Advances in Musculoskeletal Disease|July 22, 2021
Immunomodulation with IL-17 and TNF-α in spondyloarthritis: focus on the eye and the central nervous systemElsa How Shing Koy, Pierre Labauge, Athan Baillet, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 25, 2025
Combination Therapy Using Embolization, Gelified Alcohol Sclerotherapy, and Vertebroplasty to Treat Aggressive Vertebral Hemangioma: Technique and Initial ResultsSylvain Grange, Thierry Thomas, Lucile Grange, et al.
Joint Bone Spine|August 1, 2017
Retro-odontoid pseudo-tumor due to calcium pyrophosphate crystal deposits with spinal cord compression and histopathological confirmationLambert Mijola, Adamah Amouzougan, Fabrice-Guy Barral, et al.
Journal of Clinical Medicine|April 18, 2019
How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?-MTX in the Treat-to-Target StrategyPeter C Taylor, Alejandro Balsa Criado, Anne-Barbara Mongey, et al.
Mediators of Inflammation|September 6, 2019
Implication of IL-17 in Bone Loss and Structural Damage in Inflammatory Rheumatic DiseasesBenoit Le Goff, Béatrice Bouvard, Thierry Lequerre, et al.
Arthritis and Rheumatism|June 28, 2006
Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatmentMyew-Ling Toh, Hubert Marotte, Jean-Luc Blond, et al.
Joint Bone Spine|January 14, 2021
Factors associated with back complaints among French medical studentsCarole Pelissier, Joséphine Lemaitre, Hubert Marotte, et al.
Advances in Therapy|July 28, 2025
Real-World Effectiveness and Safety of Infliximab Biosimilar CT-P13 for Rheumatic Diseases: A National Observational Cohort Study (ReFLECT)Hubert Marotte, Alain Cantagrel, Fabienne Coury, et al.
Pageof 15